COMPANY PROFILE · UPDATED 18 NOV 2025

Harpoon Therapeutics

Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. T cell engagers are…

harpoontx.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2015
Headcount: 53
Open roles: 0
Last raised: Post Ipo Equity · Sign in to view

LEADERSHIP

Founders & key people

OPEN ROLES

Hiring at Harpoon Therapeutics

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total raised

$255,000,000

Funding rounds

Post Ipo Equity
$100MOct 23, 2023
Post Ipo Equity
Lion Point Capital, Surveyor Capital, Commodore Capital, New Leaf Venture Partners, Ally Bridge Group, Cormorant Asset Management, RA Capital Management, Soleus Capital, Invus, K2 HealthVentures
$100MOct 22, 2023
Post Ipo Equity
$25MMar 27, 2023
Post Ipo Equity
Invus, OrbiMed Advisors, Arix Bioscience, K2 HealthVentures, New Leaf Venture Partners
$25MMar 26, 2023
IPO
UndisclosedFeb 7, 2019
IPO
UndisclosedJan 1, 2019
Series C
$70MNov 12, 2018
Series C
New Leaf Venture Partners, OrbiMed Advisors, Ridgeback Capital Management, Arix Bioscience, Taiho Ventures, MPM Capital, UBS Asset Management, Lilly Asia Ventures, NS Investment, oncology impact fund
$70MNov 11, 2018
Series B
$45MMay 25, 2017
Series B
Arix Bioscience, MPM Capital, New Leaf Venture Partners, Taiho Ventures, UBS Asset Management
$45MMay 24, 2017
Series A
$15MApr 1, 2016
Series A
MPM Capital, UBS Asset Management
$15MMar 31, 2016

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Industries

Medical Organizations Health Care Companies Biotechnology Companies

LOCATIONS

Where they work

Harpoon Therapeutics Headquarters Location

4000 Shoreline Ct suite 250, South San Francisco, CA, 94080

Loading map…